Philip Morris International Reports Q2 2025 Results: Revenue Reaches $10.14 Billion as Smoke-Free Products Rise to 41% of Total Sales

Jul.22.2025
Philip Morris International Reports Q2 2025 Results: Revenue Reaches $10.14 Billion as Smoke-Free Products Rise to 41% of Total Sales
On July 22, Philip Morris International (PMI) reported Q2 2025 earnings with net revenue of $10.14 billion, up 7.1% year-over-year. Smoke-free product revenue reached $4.2 billion (41% of total), growing 14.5% organically. Heated tobacco shipments hit 38.8 billion units; e-vapor shipments more than doubled; nicotine pouch volume rose 43.3%. IQOS market share in Japan climbed to 31.7%. PMI raised its full-year EPS guidance to $7.24–$7.37.

Philip Morris International (PMI) reported robust financial results for the second quarter of 2025, with total net revenues reaching $10.14 billion, a 7.1% increase compared to the same period last year. Adjusted diluted earnings per share (EPS) rose 20.1% to $1.91, while reported diluted EPS increased 26.6% to $1.95.

 

The company’s smoke-free product (SFP) segment delivered particularly strong performance, with net revenues up 15.2% and gross profit rising 23.3%. Despite a 1.5% decline in combustible cigarette shipments, revenue from the combustibles segment grew 2.1%, driven by effective pricing strategies. Gross profit from combustibles rose 5.0%.

 

PMI declared a quarterly dividend of $1.35 per share, or $5.40 on an annualized basis, and raised its full-year earnings guidance. The company now expects adjusted diluted EPS to grow between 13% and 15% for the full year 2025.

 

Key Q2 2025 Figures

Net revenues: $10.14 billion (+7.1% YoY)

Reported diluted EPS: $1.95 (+26.6%)

Adjusted diluted EPS: $1.91 (+20.1%)

Smoke-free product revenue: $4.2 billion (+15.2%, 41% of total)

Combustible product revenue: $6.0 billion (+2.1%)

Operating income: $3.71 billion (+7.8%)

Quarterly dividend: $1.35 per share (annualized: $5.40)

 

Smoke-Free Product Highlights

PMI’s smoke-free portfolio accounted for 41% of net revenues and over 42% of gross profit. Shipment volume rose 11.8% from a year ago. IQOS, PMI’s flagship heat-not-burn product, surpassed $3 billion in quarterly revenues and reached a 9.2% share of global cigarette and HTU volumes.

 

IQOS HTU shipment volume reached 38.8 billion units (+9.2% YoY), with adjusted market share in Japan rising to 31.7%, and in Europe to 10.9%.

 

Nicotine pouch shipments rose to 214.7 million cans globally (+43.3%), including 191.3 million in the Americas. Snus shipments totaled 59.6 million cans (+1.4%).

 

VEEV, PMI’s e-vapor brand, more than doubled its global shipment volume. It is now sold in 42 markets and ranks first in closed-pod sales in six European countries, including Greece and Italy.

 

Combustibles Segment

Cigarette shipments declined 1.5% to 155.2 billion units. However, revenue in this segment grew 2.1%, supported by favorable pricing. Gross profit increased 5.0%.

 

Regional Performance

Europe: shipment volume down 1.7%, smoke-free shipments up 11.7%

Southeast Asia, CIS, Middle East: shipments up 1.2%, smoke-free up 14.8%

East Asia, Australia, and Global Travel Retail: shipments up 4.1%, smoke-free up 7.2%

Americas: shipments up 6.2%, smoke-free up 30.2%

 

Outlook

PMI reaffirmed its commitment to transitioning away from combustible tobacco. The company aims to reduce cigarette volumes and accelerate adoption of smoke-free alternatives across markets.

 

For full-year 2025, PMI forecasts adjusted diluted EPS of $7.43 to $7.56, representing growth of 13% to 15%. It expects organic net revenue to grow 6% to 8% and smoke-free product shipments to rise by 12% to 14%.

 

U.S. Fifth Circuit Vacates NicQuid Vape MDO, Says FDA Comparative-Efficacy Standard Violated APA Procedures
U.S. Fifth Circuit Vacates NicQuid Vape MDO, Says FDA Comparative-Efficacy Standard Violated APA Procedures
According to VitalLaw on August 27, 2026, the U.S. Court of Appeals for the Fifth Circuit vacated an FDA marketing denial order (MDO) against NicQuid LLC, ruling that the agency’s comparative-efficacy standard for electronic nicotine delivery system (ENDS) applications had become a substantive rule requiring notice-and-comment rulemaking under the Administrative Procedure Act (APA). The court did not reject FDA’s authority to compare the public health benefits and risks of flavored vapes, but held that the agency could not establish a broadly binding standard through informal adjudications. The case was remanded to FDA for further proceedings.
Aug.28
After Apple Business Decline, South Korea’s ITM Semiconductor Expands KT&G Vape Supply Chain as Vape Revenue Rises 24.8%
After Apple Business Decline, South Korea’s ITM Semiconductor Expands KT&G Vape Supply Chain as Vape Revenue Rises 24.8%
South Korean electronics component supplier ITM Semiconductor is reshaping its business portfolio after a decline in Apple-related protection circuit business, expanding its supply of vape devices and cartridges to KT&G. According to News1 on August 18, 2026, ITM’s vape-related revenue rose 24.8% year on year to 75.5 billion won in the first half of 2026. The company began mass production of vape devices at its Cikarang, Indonesia facility in January 2026, strengthening export manufacturing capacity. Meanwhile, Samsung-related protection circuit sales continued to grow, providing support during the transition.
Aug.20
Philippines Weighs Unified Vape Tax as Lawmakers Back Risk-Based Rates and Government Seeks to Fill ₱66 Billion Revenue Gap
Philippines Weighs Unified Vape Tax as Lawmakers Back Risk-Based Rates and Government Seeks to Fill ₱66 Billion Revenue Gap
Philippine lawmakers are considering an overhaul of the country's vape excise-tax regime to eliminate the wide gap between taxes on nicotine salt and freebase nicotine liquids and reduce incentives for misdeclaration. House Bill 5364, filed by Rep. Rufus Rodriguez and Rep. Maximo Rodriguez Jr., would impose a unified ₱10-per-milliliter tax on vapor products, with 5% annual increases beginning in 2027. Rodriguez says the proposal could generate an average ₱6 billion in annual collections from 2027 through 2030. The debate comes as the Philippine government considers tobacco, vape and other health-tax reforms to help offset around ₱66 billion in revenue expected to be forgone under a proposed tax-relief package.
Aug.18
Science | International Experts Propose a New Smoking Cessation Pathway, Citing Higher Quit Rates With E-Cigarettes Than Nicotine Replacement Therapy
Science | International Experts Propose a New Smoking Cessation Pathway, Citing Higher Quit Rates With E-Cigarettes Than Nicotine Replacement Therapy
A new expert paper in JAMA urges U.S. clinicians to include nicotine e-cigarettes in smoking-cessation discussions, citing higher quit rates than nicotine replacement therapy. It also stresses that products must deliver enough nicotine to replace cigarettes, dual use should be brief, and complete switching is the goal. 2Firsts argues the recommendations matter beyond clinics: public-health professionals should reassess relative risk, regulators should preserve sufficient product appeal for adult smokers, and manufacturers should focus on helping users quit cigarettes more sustainably.
SCIENCE
Aug.03 by 2Firsts Perspectives
U.S. Customs Plan to Require Foreign Export Declarations Could Deal ‘Devastating’ Blow to China’s Vape Exports, Logistics gl Expert Says
U.S. Customs Plan to Require Foreign Export Declarations Could Deal ‘Devastating’ Blow to China’s Vape Exports, Logistics gl Expert Says
A U.S. Customs and Border Protection proposal to collect foreign export declarations and other overseas customs documents could expose discrepancies in the value, classification and description of China-made vape shipments entering the United States. A veteran Chinese logistics professional told 2Firsts that the measure, if implemented, could undermine the all-inclusive shipping model used by some unauthorized vape exporters and push parts of the trade toward costlier underground channels. The risk extends beyond higher duties: accurately declared products may also be more readily identified as unauthorized e-cigarettes subject to FDA enforcement.
Special Report
Sep.07
JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
A study by CDC Foundation researchers found no sustained decline in e-cigarette sales across Alabama, Oklahoma and Louisiana, the first three U.S. states to implement e-cigarette directory laws. Louisiana initially saw a significant sales decline, followed by a rebound and a persistent reduction in product availability. Sales also shifted from nontobacco-flavored disposables toward prefilled cartridges, with Vuse Alto driving much of the increase in menthol cartridges. By April 2025, unlisted products still accounted for more than half of e-cigarette nicotine sales in all three states.
Sep.18